Medcura Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 29

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $22.4M

  • Investors
  • 16

Medcura General Information

Description

Developer of a wound care platform designed to be used across a broad spectrum of clinical and non-clinical setups for managing many high-impact surgical bleeds. The company's platform transforms highly abundant natural materials into advanced wound treatment and hemostatic products for surgical, military and consumer applications, antibacterial barriers and a robust and diverse range of products that innovatively control bleeding, enabling doctors to improve bleeding management while creating antibacterial barriers and enhancing healing environments.

Contact Information

Formerly Known As
Remedium Technologies, gel-e
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Outcome Management (Healthcare)
Decision/Risk Analysis
Other Pharmaceuticals and Biotechnology
Corporate Office
  • 5650 Rivertech Court
  • Suite S
  • Riverdale, MD 20737
  • United States
+1 (612) 000-0000

Medcura Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Medcura Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
17. Later Stage VC 03-Apr-2024 $22.4M 000.00 Completed Pre-Clinical Trials
16. Grant 31-Oct-2023 000.00 000.00 Completed Pre-Clinical Trials
15. Later Stage VC (Series A1) 08-Sep-2022 00.00 000.00 000.00 Completed Generating Revenue
14. Grant 31-Dec-2021 00.000 000.00 Completed Pre-Clinical Trials
13. Secondary Transaction - Private 000.00 Completed Generating Revenue
12. Later Stage VC 01-Nov-2021 00.00 000.00 000.00 Completed Generating Revenue
11. Later Stage VC (Series A) 12-Aug-2021 00.000 0000 000.00 Completed Generating Revenue
10. Later Stage VC (Series A) 21-Sep-2020 00.000 00.000 0000 Completed Generating Revenue
9. Grant 31-Dec-2018 $1.4M $5.53M Completed Pre-Clinical Trials
8. Angel (individual) 31-Dec-2018 $2.43M $5.53M Completed Generating Revenue
To view Medcura’s complete valuation and funding history, request access »

Medcura Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-1 0,000,000 00.000000 00.0 00.0 00 00.0 000
Series A 0,000,000 00.000000 00.00 00.00 00 00.00 00.000
Seed 6,199,999 $0.001000 $0.5 $0.5 1x $0.5 18.85%
To view Medcura’s complete cap table history, request access »

Medcura Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a wound care platform designed to be used across a broad spectrum of clinical and non-clinical setups for m
Biotechnology
Riverdale, MD
29 As of 2024
000.00
0000000000 0 000.00

000000

g elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut en
0000000000000
Schlieren, Switzerland
00 As of 0000
000.00
00000 0000-00-00
0000000000 0 000.00

000000

d exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aut
0000000000000
Houston, TX
00 As of 0000
0000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Medcura Competitors (4)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
InSphero Venture Capital-Backed Schlieren, Switzerland 00 000.00 0000000000 0 000.00
Synthecon Accelerator/Incubator Backed Houston, TX 00 0000000000
Prellis Biologics Venture Capital-Backed San Francisco, CA 00 000.00 00000000000 000.00
Aspect Biosystems Venture Capital-Backed Vancouver, Canada 000 000.00 000000000000 000.00
To view Medcura’s complete competitors history, request access »

Medcura Patents

Medcura Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240032943-A1 Vascular bleeding control device and methods of use Pending 29-Aug-2020 00000000000
CA-3156813-A1 Hydrophobically-modified biopolymer materials Pending 03-Oct-2019 000000000
US-20220347341-A1 Hydrophobically-modified biopolymer materials Pending 03-Oct-2019 000000000
EP-3934659-A1 System and method to reduce tissue or organ adhesion Pending 05-Mar-2019 0000000000
EP-3934659-A4 System and method to reduce tissue or organ adhesion Pending 05-Mar-2019 A61K31/722 0
To view Medcura’s complete patent history, request access »

Medcura Executive Team (12)

Name Title Board Seat Contact Info
James Buck Chief Executive Officer, President & Board Member
John Barry Ph.D Chief Operating Officer
Rachel Hoffman Senior Vice President, Clinical and Regulatory Affairs
Steven Ford Senior Vice President, Marketing and Business Development
Larry Tiffany JD Co-Founder & Executive Chairman
You’re viewing 5 of 12 executive team members. Get the full list »

Medcura Board Members (8)

Name Representing Role Since
Abbas Ardehali MD Self Board Member 000 0000
Jacob Rodman Self Board Member 000 0000
James Buck Medcura Chief Executive Officer, President & Board Member 000 0000
Katherine Hill Ritchie TEDCO Board Observer 000 0000
Larry Tiffany JD Medcura Co-Founder & Executive Chairman 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Medcura Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Medcura Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Aspira Capital Management Venture Capital Minority 000 0000 000000 0
Denniston Family Office Family Office Minority 000 0000 000000 0
HBS Alumni Angels of Greater New York Angel Group Minority 000 0000 000000 0
Ironwood Investment Management Venture Capital Minority 000 0000 000000 0
Aubrey Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 16 investors. Get the full list »

Medcura FAQs

  • When was Medcura founded?

    Medcura was founded in 2007.

  • Who is the founder of Medcura?

    Larry Tiffany JD and Matthew Dowling Ph.D are the founders of Medcura.

  • Who is the CEO of Medcura?

    James Buck is the CEO of Medcura.

  • Where is Medcura headquartered?

    Medcura is headquartered in Riverdale, MD.

  • What is the size of Medcura?

    Medcura has 29 total employees.

  • What industry is Medcura in?

    Medcura’s primary industry is Biotechnology.

  • Is Medcura a private or public company?

    Medcura is a Private company.

  • What is Medcura’s current revenue?

    The current revenue for Medcura is 00000.

  • How much funding has Medcura raised over time?

    Medcura has raised $49.8M.

  • Who are Medcura’s investors?

    Aspira Capital Management, Denniston Family Office, HBS Alumni Angels of Greater New York, Ironwood Investment Management, and Aubrey Capital are 5 of 16 investors who have invested in Medcura.

  • Who are Medcura’s competitors?

    InSphero, Synthecon, Prellis Biologics, and Aspect Biosystems are competitors of Medcura.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »